Please login to the form below
Freeline
This page shows the latest Freeline news and features for those working in and with pharma, biotech and healthcare.
$450m diagnostics sale will fuel more Syncona biotech funding
This will help frees up its portfolio for new investments. Since 31 March 2019, Syncona has invested £64.1min to its portfolio companies, including gene therapy companies Freeline and Gyroscope and
Latest news
-
Syncona launches another cell therapy company, Treg specialist Quell
Quell is the tenth life science company founded by Syncona, with other UK-based cell and gene therapy companies on its roster including Gyroscope and Freeline.
-
Novartis and Syncona back new Swiss biotech Anaveon
These include Freeline, which last year raised £88m to accelerate haemophilia gene therapy, and Gyroscope, which earlier this month dosed its first patient with its gene therapy for dry AMD, and
-
UniQure edges closer to haemophilia B gene therapy OK
Also in the hunt is UK-German biotech Freeline, which reported preliminary data from a phase 1/2 trial of its FLT180a candidate at last year’s American Society of Haematology
-
UniQure skyrockets on haemophilia B gene therapy data
Another emerging competitor is UK start-up Freeline Therapeutics, which has just raised around $112m to help advance its haemophilia B gene therapy candidate which has also shown early promise in
-
UniQure’s starts pivotal haemophilia B gene therapy trial
Another emerging competitor is UK start-up Freeline Therapeutics, which has just raised around $112m to help advance its haemophilia B gene therapy candidate which has also shown early promise in
Syncona launches another cell therapy company, Treg specialist Quell
Novartis and Syncona back new Swiss biotech Anaveon
UniQure edges closer to haemophilia B gene therapy OK
UniQure skyrockets on haemophilia B gene therapy data
UniQure’s starts pivotal haemophilia B gene therapy trial
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Anne Prener to lead Freeline Therapeutics
She joins from Gyroscope Therapeutics to take up CEO role. London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer. ... Frener said: “I am excited to be joining
Anne Prener to lead Freeline Therapeutics
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Publications Director
-
Competitive Salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Medical Editor
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Associate Account Director
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Merck & Co reveals plans for women’s health spinoff Organon
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- bluebird bio aiming to separate business units by year-end
- FDA accepts BMS’ investigational cardiovascular drug mavacamten for review
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- Clark Health promotes Siân Hurst to managing director role
- ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
- EMA introduces new measures to enable flexibility for non-COVID-19 procedures
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Merck & Co reveals plans for women’s health spinoff Organon
- Virtual agency The Difference Collective makes new hires to senior team
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- The impact of cancer on mental health during COVID-19
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
